Previous Close | 2.1000 |
Open | 2.1200 |
Bid | 1.9800 x 4000 |
Ask | 1.9900 x 4000 |
Day's Range | 2.0800 - 2.2400 |
52 Week Range | 1.6400 - 2.6400 |
Volume | |
Avg. Volume | 2,259,990 |
Market Cap | 855.624M |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3000 |
Earnings Date | May 07, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.94 |
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 36th Annual Roth Conference on Monday, March 18, 2024, at 8:30AM PT. A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group Inc.Cronos is an innovative g
Key Takeaways; Cannabis Sector Key Takeaways; Psychedelic Sector In a rollercoaster week for MSOs, the cannabis industry faced both triumphs and challenges. Despite many positive Q4 reports in late February, this week witnessed an unusual trend as only a few large MSO reported their financials. Surprisingly, the market responded with increased selling even after companies […]
Cronos Group ( TSE:CRON ) Full Year 2023 Results Key Financial Results Revenue: US$87.2m (flat on FY 2022). Net loss...